Department of Rehabilitation Medicine, Weill Cornell Medical Center, 10065 New York, USA.
J Rehabil Med. 2013 Jun;45(6):519-27. doi: 10.2340/16501977-1138.
To further examine the psychometric properties of a 9-item version of the Arm Motor Ability Test (AMAT-9) in persons with stroke.
Thirty-two community-dwelling persons > 6 months post-stroke undergoing robotics treatment (mean age = 56.0 years, time post-stroke = 4.1 years, National Institutes of Health Stroke Scale score = 4.1, and AMAT-9 score = 1.22).
Construct validity (including Rasch analyses) used baseline data prior to treatment (n = 32). Standardized response mean was calculated for subjects completing the protocol (n = 29). The Wolf Motor Function Test (WMFT), Fugl-Meyer Assessment (FMA), Action Research Arm Test (ARAT), and Stroke Impact Scale (SIS) were also administered.
Spearman-rank correlation coefficients between AMAT-9 and the WMFT, FMA, and ARAT were strong (0.78-0.79, all p < 0.001). The correlation between the AMAT-9 and SIS Hand Function sub-score was stronger than that between the AMAT-9 and the Communication sub-score (0.40, p = 0.025 and -0.16, p = 0.39, respectively). Rasch analyses provided evidence for an appropriate hierarchical structure of item difficulties, unidimensionality, and good reliability. The AMAT demonstrated a comparable standardized response mean of 0.98.
The AMAT-9 is valid and responsive among subjects scoring in the lower range of the scale. It has the advantage of assessing function and by eliminating the standing item from the previous iteration, it may be more easily used with severely impaired patients.
进一步研究脑卒中患者手臂运动能力测试(AMAT-9)的 9 项版本的心理计量学特性。
32 名在社区居住的脑卒中后患者,正在接受机器人治疗(平均年龄为 56.0 岁,发病后时间为 4.1 年,国立卫生研究院卒中量表评分为 4.1,AMAT-9 评分为 1.22)。
使用治疗前的基线数据(n=32)进行结构有效性(包括 Rasch 分析)。对完成方案的受试者(n=29)计算标准化反应均值。还进行了 Wolf 运动功能测试(WMFT)、Fugl-Meyer 评估(FMA)、动作研究手臂测试(ARAT)和卒中影响量表(SIS)。
AMAT-9 与 WMFT、FMA 和 ARAT 之间的 Spearman 等级相关系数较强(0.78-0.79,均 p<0.001)。AMAT-9 与 SIS 手功能子评分之间的相关性强于与 SIS 交流子评分之间的相关性(0.40,p=0.025 和-0.16,p=0.39)。Rasch 分析提供了证据,证明项目难度的适当层次结构、单维性和良好的可靠性。AMAT 表现出可比的标准化反应均值 0.98。
在得分处于量表较低范围内的受试者中,AMAT-9 是有效和敏感的。它具有评估功能的优势,并且通过从以前的迭代中消除站立项目,它可能更容易用于严重受损的患者。